{"groups":[{"description":"All participants enrolled.\n\n5-Azacitidine: Administered on Days 1-7 of each Cycle.\n\nSubcutaneous administration:\n\nTo provide a homogeneous suspension, the contents of the syringe must be re-suspended by inverting the syringe 2-3 times and vigorously rolling the syringe between the palms for 30 seconds immediately prior to administration.\n\nThe 5-azacitidine suspension is administered subcutaneously.\n\nIntravenous Administration:\n\n5-Azacitidine solution is administered intravenously. Administer the total dose over a period of 10-40 minutes.","id":"FG000","title":"Arm 1 - 5-Azacitidine"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"11"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"11"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}